JAGUAR HEALTH, INC. Inventory, Work in Process, Gross
JAGUAR HEALTH, INC. (JAGX) had Inventory, Work in Process, Gross of $6.83 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-19
- 2026-06-30: Inventory, Work in Process, Gross $6.83M.
- 2026-03-31: Inventory, Work in Process, Gross $6.91M.
- 2025-12-31: Inventory, Work in Process, Gross $7.24M.
- 2025-09-30: Inventory, Work in Process, Gross $7.41M.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2026-06-30 | $6.83M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $6.91M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $7.24M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $7.41M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $7.61M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $7.72M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $7.41M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $7.01M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $6.83M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $6.13M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $6.52M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.72M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.40M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.38M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.60M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $3.06M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.04M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $2.42M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.76M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $2.20M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $1.71M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.48M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.03M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $542.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $875.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.23M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $1.21M 10-K · filed 2021-03-31 | $1.21M 10-K · filed 2020-04-03 |
| 2018-12-31 | $2.67M 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |